title: Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism.
abstract: Osteocalcin (OC) has been proposed as a regulator of insulin sensitivity in both humans and other animals. Primary hyperparathyroidism (PHPT) is characterized by high OC levels and insulin resistance. The aim of this study was to evaluate whether in PHPT the link between OC levels and blood markers of insulin resistance was maintained. In a consecutive series of 219 adult PHPT patients, serum OC as well as fasting insulin and glucose levels were measured. Insulin sensitivity was estimated by homeostatic model assessment (HOMA2-S%). The same parameters were evaluated in a subgroup of 45 patients after parathyroidectomy (PTX). PHPT patients were characterized by markedly high OC levels. After subdividing them according to glucose tolerance, it was found that OC was similar in subjects with normal glucose tolerance (NGT) and impaired glucose tolerance (IGT), while diabetic subjects had lower serum OC than those with NGT (P < 0.02) or IGT (P < 0.04). OC was negatively associated with fasting glucose and positively associated with HOMA2-S%. OC independently predicted HOMA2-S% in a multivariate analysis. In the subgroup of surgically cured PHPT patients, OC levels significantly decreased after PTX, while HOMA2-S% did not change. Our findings indicate that in PHPT there is a positive relationship between OC and glucose metabolism, OC being one of the predictors of insulin sensitivity. However, data in surgically cured patients, showing OC normalization in spite of unchanged HOMA2-S%, suggest that OC does not likely play a major role in affecting insulin sensitivity in PHPT.
authors.affiliation: Division of Endocrinology and Metabolism, S. Croce & Carle Hospital, Cuneo, Italy. laura.gianotti@unito.it
authors.forename: L
authors.initials: L
authors.lastname: Gianotti
authors.forename: A
authors.initials: A
authors.lastname: Piovesan
authors.forename: C G
authors.initials: CG
authors.lastname: Croce
authors.forename: M
authors.initials: M
authors.lastname: Pellegrino
authors.forename: C
authors.initials: C
authors.lastname: Baffoni
authors.forename: F
authors.initials: F
authors.lastname: Cesario
authors.forename: G
authors.initials: G
authors.lastname: Visconti
authors.forename: G
authors.initials: G
authors.lastname: Borretta
authors.forename: F
authors.initials: F
authors.lastname: Tassone
mesh_terms: D000328:Adult; D000368:Aged; D015992:Body Mass Index; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D005260:Female; D018149:Glucose Intolerance / Q000097:blood / Q000150:complications / Q000378:metabolism; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000097:blood* / Q000150:complications / Q000378:metabolism* / Q000601:surgery; D007333:Insulin Resistance / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000097:blood*; D016105:Parathyroidectomy; D012189:Retrospective Studies
chemical_list: D015675:Osteocalcin